Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Table 1

The demographic and baseline clinical parameters before treatment in 40 CL patients allocated to receive treatment with Shiunko and placebo.

Parameters	Placebo; ()	Shiunko; ()
Age [median (range), years]	40.4 (18–53)	38.1 (18–62)
Sex [number of males and females]	12, 8	13, 7
Lesion sign
Lesion size [median (range), mm^2]	91 (16–1,575)	123 (13–1,578)
Lesion location [ (%)]
Face	17 (85)	15 (75)
Neck	2 (10)	1 (5)
Arm	1 (5)	3 (15)
Eyelid	0 (0)	1 (5)